WHO: ‘Very High Risk’ That Ebola Will Spread From Congo
Agency says two cases of the deadly virus were confirmed near the border with Uganda
FDA Approves New Treatment for Squamous Cell Carcinoma
Libtayo is the sixth FDA-approved immune checkpoint inhibitor targeting the PD-1 pathway
FDA Approves New Drug for Antibiotic-Resistant Lung Disease
Arikayce approved to treat lung disease caused by Mycobacterium avium complex bacteria
Nintedanib Plus Sildenafil No Better Than Nintedanib in IPF
No benefit with sildenafil in idiopathic pulmonary fibrosis with severe impairment in gas exchange
Proton Pump Inhibitor Use Tied to Hip Fracture in Dialysis Patients
Correlation between PPI and hip fracture persisted for subgroups with low, medium, high PPI use
Increased Cardiovascular Risk for Diclofenac Initiators
Increased risk compared with NSAID non-initiators, initiators of acetaminophen, ibuprofen, naproxen
Pharmaceutical Executive Defends 400 Percent Price Hike
Price for nitrofurantoin increased from $474.75 to $2,392 in August; exec cites 'moral imperative'
Practices Should Set Rules for Staff Social Media Use
Staff social media accounts should be strictly personal, with no info about patients or employees
Single Agent Treats Two Cancers With Same Genetic Cause
Pembrolizumab treated colon cancer, intrahepatic cholangiocarcinoma in patient with Lynch syndrome
Newer Hormonal Contraception May Cut Ovarian Cancer Risk
Combined hormonal contraception use tied to lower risk; risk down with increasing duration of use
